SMARCA4 and liver cancer: Thus, an inevitable yet intriguing question to ask is whether or not this E2F5-TFDP1-BRG1-MYCN axis could differentiate signals that instigate physiological hepatocyte proliferation (i.e., liver regeneration) and those that stimulate pathological hepatocyte proliferation (i.e., liver cancer).